Efficacy of oral sirolimus as salvage therapy in refractory lichen planus associated with immune deficiency

Br J Dermatol. 2018 Sep;179(3):771-773. doi: 10.1111/bjd.16555. Epub 2018 Jun 26.

Authors

T Mahévas¹, R Bertinchamp², M Battistella^{3

4}, P Reygagne⁵, E Oksenhendler^{2

4}, C Fieschi^{2

4}, H Bachelez^{1

4

6}

Affiliations

¹ Dermatology Department, AP-HP Hôpital, Saint-Louis, Paris, France.
² Clinical Immunology Department, AP-HP Hôpital, Saint-Louis, Paris, France.
³ Pathology Department, AP-HP Hôpital, Saint-Louis, Paris, France.
⁴ Sorbonne Paris Cité Université Paris Diderot, Paris, France.
⁵ Sabouraud Center, Saint-Louis Hospital, Paris, France.
⁶ UMR INSERM 1163, Institut Imagine, Hôpital Necker, Paris, France.

PMID: 29573394
DOI: 10.1111/bjd.16555

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Adult
Betamethasone / therapeutic use
Biopsy
Drug Resistance
Drug Therapy, Combination / methods
Female
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunologic Deficiency Syndromes / drug therapy*
Immunologic Deficiency Syndromes / immunology
Lichen Planus / drug therapy*
Lichen Planus / immunology
Lichen Planus / pathology
Middle Aged
Photopheresis
Salvage Therapy / methods*
Sirolimus / therapeutic use*
Skin / pathology
Treatment Outcome

Substances

Immunoglobulins, Intravenous
Betamethasone
Sirolimus